192
Views
48
CrossRef citations to date
0
Altmetric
Research Article

Terfenadine–β-Cyclodextrin Inclusion Complex with Antihistaminic Activity Enhancement

, , , , , , , & show all
Pages 857-862 | Published online: 30 Jun 2001

REFERENCES

  • Jayanthi G., Jayaswal S. B., Srivastava A. K. Formulation and Evaluation of Terfenadine Microballoons for Oral Controlled Release. Pharmazie 1995; 50: 769–770
  • Menhendre R. P., Samnt B. A., Sovani S. M., Tipnis H. P. Bioequivalence of Terfenadine Formulations by Pharmacodynamic Method in Human Volunteers. Indian Drugs 1993; 30: 494–497
  • El-Nahhas S. A. Solubilization of Terfenadine by Gentisate Hydrotropes. Pharmazie 1997; 52: 624–627
  • Ubaldo C., Albo L. M., Paolo G. Processing for Preparing Pharmaceutical Compositions Having an Increased Active Substance Dissolution Rate, and the Composition Obtained. EP 0 468 392 A1, 1991
  • Abosehmah-Albidy A. Z., York P., Wong V., Losowsky M. S., Chrystyn H. Improved Bioavailability and Clinical Response in Patients with Chronic Liver Disease Following the Administration of a Spironolactone: β-Cyclodextrin Complex. Br. J. Clin. Pharmacol. 1997; 44(1)35–39
  • Ammar H. O., Ghorab M., El-Nahhas S., Omar S. M., Ghorab M. M. Improvement of Some Pharmaceutical Properties of Drugs by Cyclodextrin Complexation. 5. Theophylline. Pharmazie 1996; 51(1)42–46
  • Jarvinen T., Jarvinen K., Schwarting N., Stella V. J. β-Cyclodextrin Derivatives, SBE4-β-CD and HP- β-CD, Increase the Oral Bioavailability of Cinnarizine in Beagle Dogs. J. Pharm. Sci. 1995; 84(3)295–299
  • Bekers O., Uijtendaal E. V., Beijnen J. H., Bult A., Underberg W. J.M. Cyclodextrins in the Pharmaceutical Field. Drug Dev. Ind. Pharm. 1991; 17(11)1503–1549
  • Nakai Y., Yamamoto K., Terada K., Akimoto K. The Dispersed States of Medicinal Molecules in Ground Mixtures with α- or β-Cyclodextrin. Chem. Pharm. Bull. 1984; 32(2)685–691
  • Tokumura T., Ueda H., Tsushima Y., Kasai M., Kayano M., Amada I., Nagai T. Inclusion Complexes of Cinnarizine with β-Cyclodextrin in Aqueous Solution and in the Solid State. Chem. Pharm. Bull. 1984; 32(10)4179–4184
  • Kim C. K., Choi H. G. The Interaction of Zipeprol with β-Cyclodextrin. Arch. Pharm. Res. 1987; 10(2)69–74
  • Chen T. M., Sill A. D., Housmyer C. L. Solution Stability Study of Terfenadine by High-Performance Liquid Chromatography. J. Pharm. Bio. Anal. 1986; 4(4)533–539
  • Streng W. H., Hsi S. K., Helms P. E., Tan H. G.H. General Treatment of pH-Solubility Profiles of Weak Acids and Bases and the Effects of Different Acids on the Solubility of a Weak Base. J. Pharm. Sci. 1984; 73(12)1679–1684
  • Martin U., Romer D. The Pharmacological Properties of a New, Orally Active Antianaphylactic Compound: Ketotoifen, a Benzocycloptathioophene. Drug Res. 1978; 28: 770–782
  • Pascal J. C., Beranger S., Pinhas H., Poizot A., Desiles J. P. New Antihistaminic Theophylline or Theobromine Derivatives. J. Med. Chem. 1985; 28(5)647–652

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.